UNRAVELing the synergistic effects of psilocybin and environment on brain-wide immediate early gene expression in mice. 2023

Daniel Ryskamp Rijsketic, and Austen B Casey, and Daniel A N Barbosa, and Xue Zhang, and Tuuli M Hietamies, and Grecia Ramirez-Ovalle, and Matthew B Pomrenze, and Casey H Halpern, and Leanne M Williams, and Robert C Malenka, and Boris D Heifets
Department of Anesthesiology, Perioperative and Pain Medicine, Stanford University School of Medicine, Stanford, CA, 94305, USA.

The effects of context on the subjective experience of serotonergic psychedelics have not been fully examined in human neuroimaging studies, partly due to limitations of the imaging environment. Here, we administered saline or psilocybin to mice in their home cage or an enriched environment, immunofluorescently-labeled brain-wide c-Fos, and imaged iDISCO+ cleared tissue with light sheet fluorescence microscopy (LSFM) to examine the impact of environmental context on psilocybin-elicited neural activity at cellular resolution. Voxel-wise analysis of c-Fos-immunofluorescence revealed clusters of neural activity associated with main effects of context and psilocybin-treatment, which were validated with c-Fos+ cell density measurements. Psilocybin increased c-Fos expression in subregions of the neocortex, caudoputamen, central amygdala, and parasubthalamic nucleus while it decreased c-Fos in the hypothalamus, cortical amygdala, striatum, and pallidum in a predominantly context-independent manner. To gauge feasibility of future mechanistic studies on ensembles activated by psilocybin, we confirmed activity- and Cre-dependent genetic labeling in a subset of these neurons using TRAP2+/-;Ai14+ mice. Network analyses treating each psilocybin-sensitive cluster as a node indicated that psilocybin disrupted co-activity between highly correlated regions, reduced brain modularity, and dramatically attenuated intermodular co-activity. Overall, our results indicate that main effects of context and psilocybin were robust, widespread, and reorganized network architecture, whereas context×psilocybin interactions were surprisingly sparse.

UI MeSH Term Description Entries
D011562 Psilocybin The major of two hallucinogenic components of the sacred Teonanacatl mushrooms (see PSILOCYBE), the other component being PSILOCIN. 1H-Indol-4-ol, 3-(2-(Dimethylamino)ethyl)-, Dihydrogen Phosphate (ester),Psilocybine,Psilocibin
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D006213 Hallucinogens Drugs capable of inducing illusions, hallucinations, delusions, paranoid ideations, and other alterations of mood and thinking. Despite the name, the feature that distinguishes these agents from other classes of drugs is their capacity to induce states of altered perception, thought, and feeling that are not experienced otherwise. Hallucinogen,Hallucinogenic Agent,Hallucinogenic Drug,Hallucinogenic Substance,Psychedelic,Psychedelic Agent,Psychedelic Agents,Psychotomimetic Agent,Psychotomimetic Agents,Hallucinogenic Agents,Hallucinogenic Drugs,Hallucinogenic Substances,Psychedelics,Agent, Hallucinogenic,Agent, Psychedelic,Agent, Psychotomimetic,Agents, Hallucinogenic,Agents, Psychedelic,Agents, Psychotomimetic,Drug, Hallucinogenic,Drugs, Hallucinogenic,Substance, Hallucinogenic,Substances, Hallucinogenic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D016760 Proto-Oncogene Proteins c-fos Cellular DNA-binding proteins encoded by the c-fos genes (GENES, FOS). They are involved in growth-related transcriptional control. c-fos combines with c-jun (PROTO-ONCOGENE PROTEINS C-JUN) to form a c-fos/c-jun heterodimer (TRANSCRIPTION FACTOR AP-1) that binds to the TRE (TPA-responsive element) in promoters of certain genes. Fos B Protein,Fos-Related Antigen,Fos-Related Antigens,c-fos Protein,c-fos Proteins,fos Proto-Oncogene Protein,fos Proto-Oncogene Proteins,p55(c-fos),Antigens, Fos-Related,FRAs,Proto-Oncogene Products c-fos,Proto-Oncogene Proteins fos,p55 c-fos,Antigen, Fos-Related,Fos Related Antigen,Fos Related Antigens,Protein, c-fos,Protein, fos Proto-Oncogene,Proto Oncogene Products c fos,Proto Oncogene Proteins c fos,Proto Oncogene Proteins fos,Proto-Oncogene Protein, fos,c fos Protein,c fos Proteins,fos Proto Oncogene Protein,fos Proto Oncogene Proteins,p55 c fos
D017781 Genes, Immediate-Early Genes that show rapid and transient expression in the absence of de novo protein synthesis. The term was originally used exclusively for viral genes where immediate-early referred to transcription immediately following virus integration into the host cell. It is also used to describe cellular genes which are expressed immediately after resting cells are stimulated by extracellular signals such as growth factors and neurotransmitters. Immediate Early Gene,Immediate-Early Gene,Immediate-Early Genes,Early Gene, Immediate,Early Genes, Immediate,Gene, Immediate Early,Gene, Immediate-Early,Genes, Immediate Early,Immediate Early Genes
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus

Related Publications

Daniel Ryskamp Rijsketic, and Austen B Casey, and Daniel A N Barbosa, and Xue Zhang, and Tuuli M Hietamies, and Grecia Ramirez-Ovalle, and Matthew B Pomrenze, and Casey H Halpern, and Leanne M Williams, and Robert C Malenka, and Boris D Heifets
June 2005, Brain research,
Daniel Ryskamp Rijsketic, and Austen B Casey, and Daniel A N Barbosa, and Xue Zhang, and Tuuli M Hietamies, and Grecia Ramirez-Ovalle, and Matthew B Pomrenze, and Casey H Halpern, and Leanne M Williams, and Robert C Malenka, and Boris D Heifets
July 1996, Journal of neuroscience research,
Daniel Ryskamp Rijsketic, and Austen B Casey, and Daniel A N Barbosa, and Xue Zhang, and Tuuli M Hietamies, and Grecia Ramirez-Ovalle, and Matthew B Pomrenze, and Casey H Halpern, and Leanne M Williams, and Robert C Malenka, and Boris D Heifets
January 2024, Frontiers in pharmacology,
Daniel Ryskamp Rijsketic, and Austen B Casey, and Daniel A N Barbosa, and Xue Zhang, and Tuuli M Hietamies, and Grecia Ramirez-Ovalle, and Matthew B Pomrenze, and Casey H Halpern, and Leanne M Williams, and Robert C Malenka, and Boris D Heifets
February 2023, ACS chemical neuroscience,
Daniel Ryskamp Rijsketic, and Austen B Casey, and Daniel A N Barbosa, and Xue Zhang, and Tuuli M Hietamies, and Grecia Ramirez-Ovalle, and Matthew B Pomrenze, and Casey H Halpern, and Leanne M Williams, and Robert C Malenka, and Boris D Heifets
June 2024, Data in brief,
Daniel Ryskamp Rijsketic, and Austen B Casey, and Daniel A N Barbosa, and Xue Zhang, and Tuuli M Hietamies, and Grecia Ramirez-Ovalle, and Matthew B Pomrenze, and Casey H Halpern, and Leanne M Williams, and Robert C Malenka, and Boris D Heifets
January 2012, Pharmacological reports : PR,
Daniel Ryskamp Rijsketic, and Austen B Casey, and Daniel A N Barbosa, and Xue Zhang, and Tuuli M Hietamies, and Grecia Ramirez-Ovalle, and Matthew B Pomrenze, and Casey H Halpern, and Leanne M Williams, and Robert C Malenka, and Boris D Heifets
June 1995, Psychiatry and clinical neurosciences,
Daniel Ryskamp Rijsketic, and Austen B Casey, and Daniel A N Barbosa, and Xue Zhang, and Tuuli M Hietamies, and Grecia Ramirez-Ovalle, and Matthew B Pomrenze, and Casey H Halpern, and Leanne M Williams, and Robert C Malenka, and Boris D Heifets
June 1992, Journal of neurochemistry,
Daniel Ryskamp Rijsketic, and Austen B Casey, and Daniel A N Barbosa, and Xue Zhang, and Tuuli M Hietamies, and Grecia Ramirez-Ovalle, and Matthew B Pomrenze, and Casey H Halpern, and Leanne M Williams, and Robert C Malenka, and Boris D Heifets
April 1993, Brain research,
Daniel Ryskamp Rijsketic, and Austen B Casey, and Daniel A N Barbosa, and Xue Zhang, and Tuuli M Hietamies, and Grecia Ramirez-Ovalle, and Matthew B Pomrenze, and Casey H Halpern, and Leanne M Williams, and Robert C Malenka, and Boris D Heifets
December 2008, Neuroscience,
Copied contents to your clipboard!